goserelin and Pleural-Effusion--Malignant

goserelin has been researched along with Pleural-Effusion--Malignant* in 1 studies

Other Studies

1 other study(ies) available for goserelin and Pleural-Effusion--Malignant

Article	Year
Severe flare-up in a prostate cancer patient treated with luteinizing hormone-releasing hormone analogue depot. Hinyokika kiyo. Acta urologica Japonica, 1993, Volume: 39, Issue:10 A 65-year-old man with advanced prostate cancer was treated with a luteinizing hormone-releasing hormone (LH-RH) analogue. Four days after the initial injection of 3.6 mg of goserelin acetate, severe dyspnea developed due to worsening pleuritis carcinomatosa, which was considered as a flare-up. Chest drainage was required to save his life. Therefore, we emphasize the importance of treatment to prevent tumor flare during LH-RH analogue therapy. Topics: Adenocarcinoma; Aged; Drainage; Goserelin; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Pleural Effusion, Malignant; Prostatic Neoplasms	1993

Article

Year

Severe flare-up in a prostate cancer patient treated with luteinizing hormone-releasing hormone analogue depot.

Hinyokika kiyo. Acta urologica Japonica, 1993, Volume: 39, Issue:10

A 65-year-old man with advanced prostate cancer was treated with a luteinizing hormone-releasing hormone (LH-RH) analogue. Four days after the initial injection of 3.6 mg of goserelin acetate, severe dyspnea developed due to worsening pleuritis carcinomatosa, which was considered as a flare-up. Chest drainage was required to save his life. Therefore, we emphasize the importance of treatment to prevent tumor flare during LH-RH analogue therapy.

Topics: Adenocarcinoma; Aged; Drainage; Goserelin; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Pleural Effusion, Malignant; Prostatic Neoplasms

1993